Open access peer-reviewed chapter

Hydrogels: Smart Materials in Drug Delivery

Written By

Aiswarya Sathian, Namitha Vijay, K.S. Joshy, Yogesh Bharat Dalvi and Fatima Mraiche

Submitted: 01 February 2022 Reviewed: 04 April 2022 Published: 13 July 2022

DOI: 10.5772/intechopen.104804

From the Edited Volume

Hydrogels - From Tradition to Innovative Platforms with Multiple Applications

Edited by Lăcrămioara Popa, Mihaela Violeta Ghica and Cristina-Elena Dinu-Pîrvu

Chapter metrics overview

344 Chapter Downloads

View Full Metrics

Abstract

The prominence of hydrogels in various fields of life sciences is due to their significant and functional three-dimensional biopolymeric networks, which tend to imbibe water due to -OH, -CONH2, -SO3H, -CONH,-COOR groups which have a hydrophilic tendency enabling them to be an excellent super absorbent and remain insoluble in water. Hydrogels can embed physiologically active molecules in their water-swollen network and are appealing materials for the controlled release of medicines. Several significant advancements in the realm of hydrogels for therapeutic delivery have resulted from recent advances in organic and polymer chemistry, bioengineering, and nanotechnology. We offer our perspective on the state-of-the-art in the field in this chapter, focusing on several intriguing issues such as current trends in hydrogel-based drug delivery, stimuli-responsive hydrogels, nanogels, and therapeutic release from 3D printed hydrogels. We also discuss the obstacles that must be solved to promote translation from academia to the clinic, as well as our predictions for the future of this quickly changing field of research.

Keywords

  • hydrogel
  • nanogel
  • drug delivery
  • nanocarrier

1. Introduction

Recent innovations have statured hydrogels as noteworthy drug carriers which have found their eminent application in tumor drug delivery. As it has lesser side effects than the existing systemic chemotherapy and is known to be an accurate delivering agent at specific tumor sites. In addition to this, it has salient features like biocompatibility, biodegradability, and lower toxicity than nanoparticle carriers. This has paved the way for researchers to delve into and explore more on the functionality of hydrogels. Smart hydrogels can respond to stimuli in the environment (e.g., heat, pH, light, and ultrasound), enabling in situ gelations and controlled drug release, which greatly enhances the convenience and efficiency of drug delivery [1]. The repeated monomers like homopolymers or copolymers containing hydrophilic polymer chains lead to the formation of hydrogels and these monomers are arranged in different ways, as shown in Figure 1 [3].

Figure 1.

Chemical diversity of hydrogel polymer chains (adapted from [2]).

The (3D) network of hydrogels can intake water and remain swelled in any condition without dissolving in the medium. Hydrogel carrier is trending in drug delivery due to their extended biocompatibility and tunable mechanical strength. Synthetic hydrogels are explored more because of their peculiarities like long life, higher capacity for water absorption, and high gel firmness. These can be synthesized from purely synthetic materials and these are having defined structures that can be modified to yield tailorable degradability and functionality [4].

Hydrogels are good carriers of drug delivery, and it has resulted in the elevation of therapeutic outcomes tremendously, used in clinical arenas. The delivery of cells, molecules, and macromolecular drugs in hydrogel encapsulation via spatial and temporal delivery has improved. Improving the design for the hydrogel drug delivery has overcome the limitations partially and it results in the progression of a better carrier. Current trends and different types of hydrogel drug delivery with the translation to clinical use will be discussed in this chapter [5]. There is extensive research carried out on hydrogel drug delivery. To add on, properties for drug delivery systems that were under modification, in terms of the ligands and various polymer types are researched meticulously. A wonderful disposition of a positive results was shown in the ophthalmic field i.e., from comfortable contact lenses to biodegradable drug delivery, the applications in eye care have been enormous. These possess 90% water for the drug release for a long period to deliver small or large molecules [6]. Thus, a long road of success waits for hydrogels if they are observed, studied, experimented with, and translated to clinical research.

Advertisement

2. Hydrogels for drug delivery: mechanism

Hydrogels are encompassed of 3-D hydrophilic polymer networks [7]. Since hydrogels have hydrophilic functional groups attached to the 3-D polymeric network they can absorb a huge volume of water [4]. The capability to hold water within the interconnected polymeric network aids them to swell and shrink appropriately and in turn, helps them in the application of drug delivery. Hydrogels possess porosity and compatibility with aqueous conditions hence they are considered highly promising materials for drug release [8]. Moreover, the tunable properties of hydrogels make them excellent materials for specific therapeutic applications such as oral drug administration, ocular route, nasal route, and transdermal route [9].

Hydrogels have the potential ability in oral drug delivery in particular for the delivery of macromolecules and hydrophilic drug molecules [10]. Hence the application of hydrogels has been extended to the treatment of patients with cancer and diabetics. In oral drug delivery, the drug is delivered to the following specific sites: mouth, stomach, small intestine, and colon. Hydrogels with mucoadhesive ability are mainly used for this application (Figure 2) [9].

Figure 2.

(a) The drug-containing component is coated with a hydrogel membrane and, the drug concentration is greater in the center of the system, allowing for a constant rate of release in the reservoir delivery system; and (b) Matrix delivery allows for uniform drug dissolution or dispersion across the hydrogels 3D structure (adapted from [8]).

Nowadays the significance of protein and peptide drugs is increasing due to their potent action and high selectivity but the vital problem arises due to the enzymatic activity in the GI tract that results in the degradation of these drugs. However, studies have shown that hydrogels equip a platform that aids to deliver the drugs to specific sites in the GI tract and thus have significant importance in the delivery of protein and peptide drugs through the GI tract [10]. Crosslinked hydrogels can be used to safeguard drugs from detrimental conditions including low pH in the stomach and enzymes due to the crosslinked nature of networks. Controlled diffusion of water-soluble drugs is possible in the hydrogel network. The density and chemical structure of the crosslinking agent determines mesh size [10]. An illustration of drug levels in the bloodstream is shown in Figure 3.

Figure 3.

Illustration of drug level in the blood with repeated dosing (solid line) and controlled delivery dosing (dotted line)(adapted with permission from [10]).

Another type of hydrogel called stimuli-responsive hydrogel is considered a potential substance for oral drug delivery. The peculiarities of stimuli-responsive hydrogel include the capability to respond to the changes in the environment, permeability, swelling nature, and ability to control drugs. The major objective of controlled drug delivery is to maintain a stable concentration of dose in the blood which cannot be achieved through a traditional drug release mechanism [10].

The field of eye treatment is currently employing the characteristics of hydrogels to treat the health problems such as blinking, tear drainage, and low permeability of the cornea, and the method is known as ocular route drug delivery [9].

The transdermal route of administration is another way of using hydrogels in drug delivery. This method helps to avoid drug degradation, side effects, and aids in maintaining a steady drug release. It is important to note that in comparison with conventional ointments water holding hydrogels can provide a better feeling to the skin hence this is highly preferred [9].

In reality, designing and synthesizing environmentally sensitive hydrogels offers a lot of potential in healthcare and nanotechnology applications in the future. The creation of advanced materials that can specifically address applications in biomedical issues is important to the achievement of these materials. This progress will be made through the introduction of unique polymers or the modification of existing polymers.

Advertisement

3. Current trend in hydrogel based targeted drug delivery

3.1 Supramolecular hydrogels

Supramolecular hydrogels generated by the spontaneous self-assembly of peptides, proteins, and other biomolecules have recently gathered attraction as next-generation drug delivery substitutes to synthetic polymers. Due to the comparatively expensive synthetic peptide hydrogels compared to synthetic polymer gels, self-assembling peptides are a promising class of supramolecular gelators for in vivo drug delivery that has been sluggish to catch on despite benefits in biocompatibility. Supramolecular hydrogels’ superior biocompatibility and simplicity of formulation in comparison with polymer hydrogels have sparked study into the self-assembly events that lead to gelation and how to engineer the emergent features of supramolecular gels to generate excellent drug delivery materials. The development of stimuli-responsive hydrogels for medication administration has gained the attention of researchers. Changes in pH, temperature, ionic strength, and also exposure to light, electric, and magnetic fields, are all examples of external stimuli that might cause drug release. pH-sensitive smart hydrogels have been widely used as self-regulating drug delivery systems.

The supramolecular hydrogel framework comprises non-covalent intermolecular interactions that collectively hold two or more molecular units. The non-covalent cross-linking of these hydrogels is a particularly appealing feature since it avoids the challenges of restricted drug loading capability and drug integration for use solely as implantable, which is the only option with a covalently cross-linked system. These hydrogels achieve drug loading and gelation concurrently in aqueous conditions without the need for covalent cross-linking, in addition to providing the necessary physical stability for the hydrogels. Supramolecular hydrogels based on self-assembled inclusion complexes between cyclodextrins and biodegradable block copolymers have recently made headway in providing sustained and regulated release of macromolecular medicines [8].

In recent times, supramolecular hydrogels that are responsive to biological stimuli have gained a significant amount of interest for their potential as smart materials. A macroscopic sensor could, for instance, be a stimulus-responsive gel-to-sol phase transition. In response to the stimulus-responsive gel-to-sol phase transition, a drug-encapsulated supramolecular hydrogel could deliver the drug. However, supramolecular hydrogels with a gel-to-sol phase change in response to biological stimuli must be developed under physiological settings to exploit the uses.

Supramolecular hydrogels are generally synthesized by heating followed by cooling a mixture of an LMWHG (low molecular weight hydrogelator) and an aq. solvent whereas external stimuli-triggered gelation enables the spontaneous synthesis of supramolecular hydrogels. Supramolecular hydrogels with high biocompatibility are desirable materials for medical and pharmaceutical applications. Nevertheless, the challenging preparation procedures for LMWHGs and the unavailability of very resistant supramolecular hydrogels restrict the potential possibilities of these materials. Several studies have shown that various LMWHGs can be prepared within a few steps from commercially available chemicals.

The structural tailoring of LMWHGs allows for the development of a more strong supramolecular hydrogel. Small quantities of a dimer with a similar structure to LMWHG can be added to a supramolecular hydrogel to enhance its physical characteristics. Supramolecular hydrogels with stimuli-responsive characteristics will be more beneficial. The formation of biological-stimuli-induced supramolecular hydrogels can be considered as a novel therapeutic technique based on the biological activity of self-assemblies. It is important to produce more specific and precise stimuli-responsive materials for the effective use of biological-stimuli-responsive supramolecular hydrogels [11]. The presence of competitive binders in the physiological surroundings, such as proteins or ions, is another factor to consider when designing supramolecular drug delivery vehicles. Competing interactions can impact the supramolecular hydrogel’s mechanical characteristics and/or change the release profile of loaded medicines [12].

3.2 Multicomponent hydrogels

Hydrogels that were multi-functional and carriers of anti-cancer drugs are a typical example of the versatility of these delivery vehicles and their amenability to chemical modifications to enhance their therapeutic effects. The cytocompatibility and excellent biocompatibility of the materials make them promising materials in biological applications including drug delivery, wound healing, and tissue engineering. However, during the material selection process, the potential toxicity of the breakdown products may be neglected. For instance, amazingly (polyacrylamide) is a popular breast implant that is nontoxic and has a low rate of rejection. On the other hand, the breakdown product acrylamide has medium toxicity for the neurological system and kidneys and has been classified by the World Health Organization (WHO) as one of the suspect carcinogens.

It is necessary to examine the biocompatibility of hydrogels and their degradation products for medical applications. The invention of new cost-effective biomimetic materials or natural products from high throughput processing, such as hyaluronic acid, chitosan, gelatin, collagen, and so on, could improve material safety. Stimuli-responsive hydrogels, as a kind of smart materials, offer promise for tailored drug delivery. The hydrogel structures can be triggered automictically in response to diseased microenvironments and deliver cargos with better spatial/temporal resolution thanks to an elaborate design. Nevertheless, uneven circulatory networks raised interstitial fluid pressure, and diffusion of target stimuli around the tumor microenvironment could result in unintended medication leaks and possibly off-target effects during transportation.

Furthermore, improper drug deposition in solid tumors can lead to drug resistance and a significant reduction in therapeutic benefit. This field could be advanced by drug-loaded hydrogel capsules that react to target biomarkers. Hydrogel capsules with high specificity and permeability provide a new outlook for cancer therapy250, thanks to the modification of aptamers that target certain cells. Multi-triggered hydrogels with programmable functions are also a promising technique for overcoming the challenges stated above and improving therapeutic effects. The off-target scenario might be considerably decreased if the medicine could be released in a planned logic operation in response to multiple disease/therapy-related parameters. A programmable ON/OFF switch is required for improving drug dose in various therapeutic circumstances. Incorporating cell regulators (such as peptides, proteins, and nucleic acids) into hydrogel frameworks to attract cancer cells inside and execute in situ contact-killing is another potential strategy that should be explored [13].

3.3 DNA-hydrogels

Active body regeneration scaffolds are obtained from the nucleic acid molecule of living organisms, sometimes these are known to be DNA nanostructures. Hydrogels that are made out of DNA have a uniqueness in the following characteristics; degradability, non-immunogenicity, high sensitivity, and drug delivery. The self-assembling of biomaterials works on the principle Watson–Crick base pairing and this is how the DNA hydrogels are formed. The unique mechanical and biochemical properties of DNA, along with its biocompatibility, make it a suitable material for the assembly of hydrogels with controllable mechanical properties and composition that could be used in several biomedical applications, including the design of novel multifunctional biomaterials [14]. Recent studies reported that DNA hydrogels are responsive to stimuli such as; light, biomolecules, and temperature. This stimuli-responsive helps in improving the therapeutic field as well as may decrease the side effects. Table 1 below shows the two types of triggers; nonbiological and biological [15].

Nonbiological triggersBiological triggers
LightAntigens
pHNucleic acid
Metal ionsEnzymes
TemperatureATP
Reducing agentsBiomolecules

Table 1.

Different types of triggers [15].

When a drug carrier holds features like upkeeping of intact bioactivity of drugs and inhibiting chemical and enzymatic degradation and improved retention effect it means a successful drug carrier. The benefited properties such as biocompatibility, available binding for cargos, easily triggered stimuli responsiveness, and effective active targeting ability uplifted DNA hydrogel. In a small loading efficiency, drug molecules and inorganic nanoparticles can be incorporated into the porous structured network [16]. Another highlight is to capture high performance in the deliveries of chemotherapy, immunotherapy, and gene by allowing the co-delivery agent with various physicochemical properties [17]. To inhibit the permeation of enzymes a highly crosslinked cage or network is used to deliver nucleic acid drugs and this way will protect the biological activity of the proteins. The trending research on inorganic materials delivery has inspired. Cutting down edge research has put down the obstacles and made the hydrogel drug delivery system a great progression stage over the past 2 years. To fabricate DNA hydrogel in a low-cost method with a high yield end product is a challenge in application. To overcome this challenge, it is necessary to check on the synthetic approach and it is very crucial to find a way in low-cost production for the same. Toward this end, a highly parallel gene synthesis method based on DNA microchips and specific oligonucleotide pool amplification was demonstrated. It led to a remarkable cost reduction for scale-up DNA production [18].

3.4 Stimuli-responsive hydrogels

For example, malignant tissue (pH 6.8) and endosomes/lysosomes (pH 5.5) are more acidic than normal tissue (pH 7.4), necessitating hydrogels that can deliver payload medications in response to a pH change. Several polymers have been intensively explored for the construction of intelligent hydrogels throughout the last few decades. Because of their intrinsic biocompatibility, renewability, and availability, natural-resourced polysaccharide-constructed hydrogels have gotten a lot of attention, fueling the urge to use them as drug carriers. Many polysaccharide-based hydrogels, on the other hand, lack mechanical strength rigidity and are susceptible to rapid erosion, making them unstable. This makes it difficult to use polysaccharide hydrogels for medication administration. Physical diffusions, on the other hand, are commonly used to release medicines from gel matrices, which might result in premature burst release. It’s difficult to tailor drug delivery in a predictable and on-demand manner [19].

Transitional changes occur in stimulus-responsive hydrogels in reaction to environmental factors. The concentration of certain biomolecules such as enzymes can cause them to expand, shrink, degrade, or undergo a sol-gel phase transition if there is a change shown in the temperature, pressure, ionic strength, and insolvent. This type of hydrogels is particularly valuable for therapeutic delivery because of their unique ability to perform specialized activities, such as the release of drug and in situ gel formation, in response to tiny changes in ambient circumstances.

Stimuli-responsive hydrogels that change structural or mechanical properties in reaction to environmental cues/triggers are categorized as vital subgroups in hydrogels. These hydrogels are very beneficial in robotics and biological fields. Several stimuli including light, temperature, magnetic fields, electric field, pH, and chemical and biological triggers could be used to stimulate phase transition or stiffness change of these materials implying a wide range of applications in separation, drug delivery, sensing, bionic devices, regenerative medicine, and more.

Two types of bio-stimuli called endogenous stimuli that exist naturally within the bio-environment and exogenous biocompatible stimuli that activate smart functionalities of the hydrogel system have been garnering attention for the building of bio-functional materials. pH value, metal ions, enzymes, redox environment, antigen, and other endogenous stimuli are examples of endogenous stimuli. In wounds or bacterial infections, for instance, reactive oxygen species are produced, resulting in an oxidative environment; the exocellular pH of tumor tissues is lower than normal tissues caused by abnormal metabolism, particularly glycolysis overactivity; and lung cancer cells have a particular protein that could be recognized by antibody-functionalized microgels. The application with the various stimuli is illustrated in Figure 4.

Figure 4.

Stimuli-responsive hydrogels and their applications [13].

Hydrogels ingrained with efficient cross-linkers or chemical modifications will recognize abnormal signals in pathological or wounded tissues and accomplish endogenous initiation, resulting in automated and focused behaviors such as drug delivery, cell capture, or warning signal output, with proper designing. Light, temperature, magnetic fields, electric fields, ultrasonic waves, and other exogenous stimuli are examples. Exogenous stimuli-responsive hydrogels, in contrast to endogenous stimuli-responsive hydrogels outlined above, are developed to function remotely and non-invasively [20].

It has been found that Magnetic nano-participles embedded in DNA hydrogels provide the networks with shape-adaptive and locomotion-controllable features. Light-guided fibroblast migration and angiogenesis were achieved using hydrogels treated with photo-caged RGD. The sensible integration of endogenous and exogenous stimuli-responsive units into a single hydrogel system could provide a comprehensive “toolbox” for customizing intelligent materials. The addition of programmable, multi-stimulus responsiveness enables the integration of multiple functionalities into a single hydrogel system, such as searching, recognizing, and curing. The gelator-gelator and gelator-solvent interactions are implicated in the stimuli-response pathway, which includes volume change, phase transition, and structural change.

3.5 Nanogels

The nanostructures comprising drug molecules with innovative structures represent the new frontier in the biological and medical fields. The application of nanogel in various biological fields is shown in Figure 5. The crosslinked polymer network with a three-dimensional structure and having a nanoscale size range are known to be nanogels. These nanogels can hold a large volume of water but they will not dissolve in an aqueous medium [16]. They are common in spherical shape but they can vary in the synthetic strategies [22].

Figure 5.

Schematic representation of nanogels in the various biological applications (adapted from [21]).

Nanogels have been identified recently by researchers and it has been used as a promising tool in response to the critical issues of intracellular delivery: due to their peculiar properties, including swelling behavior, nanogels can cross the cellular membrane (clathrin-mediated endocytosis, caveolin-mediated endocytosis, phagocytosis, and macropinocytosis) and release their cargo in the cytosol, avoiding the activation of immune responses. These can be fabricated using natural polymers, synthetic polymers, or a combination of both. The distinct characteristics of nanogels can be varied by their chemical composition [23].

The properties like swelling and encapsulation and the prior response in the specifically targeted sites put them in the frontline of drug delivery and gene delivery. The nanosized gel can be synthesized by two approaches; top-down and bottom-up. Generating nanoparticles from large clusters of particles by different methods (physical, chemical) is known to be a top-down approach. The imperfections in particle surfaces can be a limitation of this method. The designing and arranging of molecules by direct polymerization of monomers and assembling of polymer precursors bonding can be the bottom-up approach [24, 25]. In the biomedical application, nanogels size distribution with their stability is very important. The stability depends on the chemical composition of the polymer matrix and the crosslinking type of the polymer chains. In comparing the physical and chemical nanogels, physically crosslinked nanogels are weaker and have lesser stability, due to their stability and reproducibility the chemically crosslinked nanogels are much more attractive [26].

The schematic representation in Figure 6 shows that under a specific environmental condition the hydrogel loaded with the drug will start swelling or start shrinking and it leads to the release of a drug. This completely depends on the interaction of hydrophobic, hydrogen links, complexation, and/or coordination of drug molecules with the polymer chain networks [28]. The thermoresponsive polymeric nanogels allow the interaction of water molecules with hydrophilic groups help in swelling by maintaining its native structure. This occurs in the lower critical solution temperature (LCST), the removal of water content occurs during the hydrophobic nature. This further decreases the size of nanogel and the drug is released by the triggered temperature stimuli [29, 30]. Nanogels can be used to incorporate small nanosized molecules such as drugs and fluorophores, proteins, peptides, nucleic acids. The nanogel can act as multi-drug carriers and nanostructured gels can encapsulate multi-agents too.

Figure 6.

The schematic of drug release from the nanogel network (adapted from [27]).

Advertisement

4. Translation to the clinic research

The vast area of the potential application of hydrogel formulations has overcome barriers of in vitro/pre-clinical studies and finally found fit into the market. It is very important to have the uniqueness and the salient feature to cover the clinical-stage studies. There is a lot of research going on in the background and some of them are in the pre-clinical stage. The time to fabricate these carriers for the delivery was not at all wasted and it has all been the best and the most versatile drug delivery. Here, in Table 2, the list on the research on different hydrogel carriers for exploring the new era of therapeutic delivery is shown.

StudyHydrogelApplicationAdditional effects
(29)Cardiac ECM in PBSBulk delivery IMImproved cardiac differentiation of BADSCs
(30)Transglutaminase cross-linked gelatinBulk delivery IMImproved retention and reduced fibrosis compared to ASC in PBS, improved MIT assay, decreased ANP and TNP mRNA
(31)Alginate hydrogelMicroencapsulation IMDecreased fibrotic area and increased infarct thickness
(32)PEG hydrogelBulk delivery IMImproved retention
(33)RADA hydrogelBulk delivery IMimproved retention; hydrogel effect in itself better than BMMSCs; decreased fibrosis
(34)Alginate cross-linked with calcium glucuronateBulk delivery IMNo difference in thickness, perfusion, or fibrosis
(35)Hyaluronate hydrogelBulk delivery IMImproved retention, myocardial velocity, and strain
(36)RADA hydrogelBulk delivery IMDecreased collagen content, infarct size, number of vessels, and decreased number of apoptotic MSCs
(37)TMTD alginate hydrogelCapsules delivered epicardiallyOnly decreased fibrosis in die hydrogel group

Table 2.

Lists of the widespread practical applications of the hydrogel concept that have been translated to the clinical level.

Advertisement

5. Conclusions

Although myriad chemical moieties of the hydrogel are readily available for drug delivery. The specific problem related to hydrogel fabrication is the need to evaluate the polymer that can produce versatile hydrogels that is apt for a certain intervention that mandates the final goal of the delivery system and route of administration. Understanding the influencing elements that influence swelling behaviors, hydrophilicity, biodegradability, biocompatibility, and targetability of the selected polymer is necessary for the development of a successful hydrogel-based delivery system. Hydrogels as targeted drug delivery have several advantages, including biocompatibility, low toxicity, and good swelling behavior. There have been certain impediments in the processing of hydrogels depending on the chemical moieties of the gel-forming polymers and the route of administration, some limitations in the delivery of active pharmaceuticals, such as slow stimuli-sensitive hydrogel responsiveness, the possibility of rapid burst drug release, the possibility of drug reactivation, limited hydrophobic drug delivery, and low mechanical strength. Thus, the field of nanoscience is contributing positively to the fundamental advances in intelligent hydrogel formulation that can mimic tissues by changing their swelling and non-swelling mechanisms that directly contribute to their property as intelligent carriers that can be made use in pharmaceutical sciences.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

Advertisement

Acronym

LMWHGs

low molecular weight hydrogelator

References

  1. 1. Sun Z, Song C, Wang C, Hu Y, Wu J. Hydrogel-based controlled drug delivery for Cancer treatment: A review. Molecular Pharmaceutics. 2020;17(2):373-391. DOI: 10.1021/acs.molpharmaceut.9b01020
  2. 2. Holback H, Yeo Y, Park K. Hydrogel swelling behavior and its biomedical applications. Biomedical Hydrogels. 2011:3-24. DOI: 10.1533/9780857091383.1.3
  3. 3. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics. 2000;50(1):27-46. DOI: 10.1016/s0939-6411(00)00090-4
  4. 4. Ahmed EM. Hydrogel: Preparation, characterization, and applications: A review. Journal of Advanced Research. 2015;6(2):105-121. DOI: 10.1016/j.jare.2013.07.006
  5. 5. Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer (Guildf). 2008;49(8):1993-2007. DOI: 10.1016/j.polymer.2008.01.027
  6. 6. Hydrogel Technology – Ocular Therapeutix [Internet]. 2022. Available from: https://www.ocutx.com/about/hydrogel-technology/
  7. 7. Bahram M, Mohseni N, Moghtader M. An introduction to hydrogels and some recent applications. Emerging Concepts in Analysis and Applications of Hydrogels. 2016. Available from: https://books.google.com/books/about/Emerging_Concepts_in_Analysis_and_Applic.html?id=7XuQDwAAQBAJ [Accessed: January 27, 2022]
  8. 8. Narayanaswamy R, Torchilin VP. Hydrogels and their applications in targeted drug delivery. Molecules. 2019;24(3). DOI: 103390/molecules24030603
  9. 9. SimÕes S, Figueiras A, Veiga F. Modular hydrogels for drug delivery. Journal of Biomaterials and Nanobiotechnology. 2012;2012(2):185-199
  10. 10. Sharpe LA, Daily AM, Horava SD, Peppas NA. Therapeutic applications of hydrogels in oral drug delivery. Expert Opinion on Drug Delivery. 2014;11(6):901-915. DOI: 10.1517/17425247.2014.902047
  11. 11. Kimura S, Yokoya M, Yamanaka M. Biological-stimuli-responsive supramolecular hydrogels toward medicinal and pharmaceutical applications. Chemistry Letters. 2020;50(3):459-466. DOI: 10.1246/cl.200765
  12. 12. Bernhard S, Tibbitt MW. Supramolecular engineering of hydrogels for drug delivery. Advanced Drug Delivery Reviews. 2021;171:240-256. DOI: 10.1016/j.addr.2021.02.002
  13. 13. Li Z, Zhou Y, Li T, Zhang J, Tian H. Stimuli-responsive hydrogels: Fabrication and biomedical applications. Viewpoints. 2021;20200112. DOI: 10.1002/VIW.20200112
  14. 14. Bush J, Hu CH, Veneziano R. Mechanical properties of DNA hydrogels: Towards highly programmable biomaterials. Applied Sciences. 2021;11(4):1-20. DOI: 10.3390/app11041885
  15. 15. Wang D, Hu Y, Liu P, Luo D. Bioresponsive DNA hydrogels: Beyond the conventional stimuli responsiveness. Accounts of Chemical Research. 2017;50(4):733-739. DOI: 10.1021/acs.accounts.6b00581
  16. 16. Soni KS, Desale SS, Bronich TK. Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. Journal of Controlled Release. 2016;240:109
  17. 17. Wu HQ , Wang CC. Biodegradable smart Nanogels: A new platform for targeting drug delivery and biomedical diagnostics. Langmuir. 2016;32(25):6211-6225. DOI: 10.1021/acs.langmuir.6b00842
  18. 18. Mo F, Jiang K, Zhao D, Wang Y, Song J, Tan W. DNA hydrogel-based gene editing and drug delivery systems. Advanced Drug Delivery Reviews. 2021;168:79-98. DOI: 10.1016/j.addr.2020.07.018
  19. 19. Qi X, Wei W, Li J, Liu Y, Hu X, Zhang J, et al. Fabrication and characterization of a novel anticancer drug delivery system: Salecan/poly(methacrylic acid) semi-interpenetrating polymer network hydrogel. ACS Biomaterials Science & Engineering. 2015;1(12):1287-1299. DOI: 10.1021/acsbiomaterials.5b00346
  20. 20. Zhu Z, Ng DWH, Park HS, McAlpine MC. 3D-printed multifunctional materials enabled by artificial-intelligence-assisted fabrication technologies. Nature Reviews Materials. 2020;6(1):27-47
  21. 21. Mauri E, Perale G, Rossi F. Nanogel functionalization: A versatile approach to meet the challenges of drug and gene delivery. ACS Applied Nano Materials. 2018;1(12):6525-6541. DOI: 10.1021/acsanm.8b01686
  22. 22. Kersey FR, Merkel TJ, Perry JL, Napier ME, Desimone JM. Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores. Langmuir. 2012;28(23):8773-8781. DOI: 10.1021/la301279v
  23. 23. Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. Journal of the American Chemical Society. 2005;127(28):10096-10100. DOI: 10.1021/ja051977c
  24. 24. Oh JK, Drumright R, Siegwart DJ, Matyjaszewski K. The development of microgels/nanogels for drug delivery applications. Progress in Polymer Science. 2008;33(4):448-477. DOI: 10.1016/j.progpolymsci.2008.01.002
  25. 25. Nie Z, Xu S, Seo M, Lewis PC, Kumacheva E. Polymer particles with various shapes and morphologies produced in continuous microfluidic reactors. Journal of the American Chemical Society. 2005;127(22):8058-8063. DOI: 10.1021/ja042494w
  26. 26. Sasaki Y, Akiyoshi K. Nanogel engineering for new nanobiomaterials: From chaperoning engineering to biomedical applications. Chemical Record. 2010;10(6):366-376. DOI: 10.1002/tcr.201000008
  27. 27. Labhasetwar V, Leslie-Pelecky D. Biomedical Applications of Nanotechnology. 2007; Available from: https://books.google.com/books?hl=en&lr=&id=5kONKTdfleIC&oi=fnd&pg=PR5&ots=Bs4kagImRT&sig=mtMsWW6WRrR3qzkW3La-l53ADnQ [Accessed: January 27, 2022]
  28. 28. Jaiswal MK, Pradhan A, Banerjee R, Bahadur D. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. Journal of Nanoscience and Nanotechnology. 2014;14(6):4082-4089. DOI: 101166/jnn.2014.8662
  29. 29. Demirel G, Rzaev Z, Patir S, Pişkin E. Poly(N-isopropylacrylamide) layers on silicon wafers as smart DNA-sensor platforms. Journal of Nanoscience and Nanotechnology. 2009;9(3):1865-1871. DOI: 10.1166/jnn.2009.388
  30. 30. Satarkar NS, Hilt JZ. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. Journal of Controlled Release. 2008;130(3):246-251. DOI: 10.1016/j.jconrel.2008.06.008

Written By

Aiswarya Sathian, Namitha Vijay, K.S. Joshy, Yogesh Bharat Dalvi and Fatima Mraiche

Submitted: 01 February 2022 Reviewed: 04 April 2022 Published: 13 July 2022